QTR Family Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
QTR Family Wealth's BMY Position: Q2 2026 in Review
QTR Family Wealth reduced its Bristol-Myers Squibb (BMY) stake by 0.73% in Q2 2026, selling an estimated $9.24K and leaving 21,847 shares worth $1.26M. The position accounts for 0.44% of the portfolio, ranked #47.
QTR Family Wealth first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.28M in Q1 2026. 889 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- QTR Family Wealth held 21,847 shares of Bristol-Myers Squibb worth $1.26M as of Q2 2026.
- QTR Family Wealth sold 161 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.24K.
- Bristol-Myers Squibb made up 0.44% of QTR Family Wealth's portfolio in Q2 2026, its #47 holding.
- QTR Family Wealth first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
- QTR Family Wealth's Bristol-Myers Squibb position peaked at $1.28M in Q1 2026.
- 889 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on QTR Family Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.